Fig. 2From: Differences in tumor-infiltrating lymphocyte density and prognostic factors for breast cancer by patient ageComparison of disease-free survival (DFS) between younger and older patients with varied BC subtypes. Kaplan-Meier DFS analysis has been indicated for patients grouped based on their BC subtype as: a) all cases, b) HR+HER2-, c) HR+HER2+, d) HER2-enriched, and e) TNBC. P-values in the figure indicate statistical significance for each comparison obtained using log-rank testBack to article page